The present study investigated the influence of a recent GWAS-identified risk variant in the TMEM161B-MEF2C gene cluster for MDD on striatal activation during the anticipation of high/low rewards/losses in individuals with AD and HCs. The gene discussed is MEF2C; the disease is major depressive disorder.